Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2018 Sep;24(6):944-949.
doi: 10.1177/1076029617734308. Epub 2017 Oct 18.

Clinical Significance of the Serotonin Release Assay and Platelet Count Monitoring After Cardiac Surgery

Affiliations
Clinical Trial

Clinical Significance of the Serotonin Release Assay and Platelet Count Monitoring After Cardiac Surgery

Shinya Motohashi et al. Clin Appl Thromb Hemost. 2018 Sep.

Abstract

Heparin-induced thrombocytopenia (HIT) is one of the serious complications in patients who undergo cardiac surgery. However, there remains a major problem in diagnosing HIT because the current immunological assays for detection of HIT antibody have limitations. Furthermore, the clinical course of thrombocytopenia in this surgery makes it increasingly difficult to diagnose HIT. We investigated the relationship between platelet count and HIT antibody in 59 patients who underwent cardiac surgery using cardiopulmonary bypass (CPB). The number of postoperative HIT antibody-positive patients evaluated using enzyme-linked immunosorbent assay kit (polyanion IgG/IgA/IgM complex antibodies/antiplatelet factor 4 enhanced) was 37 (62.7%). In contrast, platelet activation by HIT antibody was evaluated using the serotonin release assay (SRA). More than 20% and 50% release of serotonin was obtained from 12 patients (20.3%) and 8 patients (13.6%), respectively. The levels of d-dimer were significantly different on postoperative day 14 between SRA-positive and SRA-negative groups; however, postoperative thrombus complication was not detected using sonography in the patients with positive serotonin release at all. After being decreased by the operation, their platelet count recovered within 2 weeks in both groups equally. In our study, although the patients were positive in the platelet activating HIT antibody assay, they remained free from thrombosis and their platelet count recovered after early postoperative platelet decrease. Therefore, in addition to the SRA, monitoring of platelet count might be still considered an indispensable factor to facilitate the prediction of HIT thrombosis prior to manifestation in the patients undergoing cardiac surgery using CPB.

Keywords: cardiac surgery; cardiopulmonary bypass; heparin-induced thrombocytopenia; platelet count monitoring; serotonin release assay.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Time course of the changes in platelet count. A, Changes in the platelet count in both groups when 20% SR was used as the cutoff level. B, Changes in platelet count in both groups when 50% SR was used as the cutoff level. SR indicates serotonin release.

Similar articles

Cited by

References

    1. Matsuo T, Motohashi S, Wanaka K, Walenga JM. Production of anti-platelet factor 4/heparin complex antibodies after cardiovascular surgery. Clin Appl Thromb Hemost. 2015;21(2):177–180. - PubMed
    1. Sheridan D, Caryer C, Kelton J. A diagnostic test for heparin-induced thrombocytopenia. Blood. 1986;67(1):27–30. - PubMed
    1. Asada R, Wanaka K, Walenga J, et al. Murine monoclonal antibody to platelet factor 4/heparin complexes as a potential reference standard for platelet activation assays in heparin-induced thrombocytopenia. Clin Appl Thromb Hemost. 2013;19(1):37–41. - PubMed
    1. Warkentin TE, Greinacher A, Gruel Y, et al. Laboratory testing for heparin-induced thrombocytopenia: a conceptional framework and implications for diagnosis. J Thromb Haemost. 2011;9(12):2498–2500. - PubMed
    1. Linkins LA, Dans AL, Moores LK, et al. Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 suppl):e495S–e530S. - PMC - PubMed

Publication types

LinkOut - more resources